Yes it will. An approval to sell in the worlds most profitable Biomed region will do it. As will actual sales in the EU, as then it moves from purely spec share to being a revenue making company which is a different beast that is treated by the market very differently. Time will tell if I am wrong on this I guess. What are your thoughts on my logic?
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market, page-15
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.002(15.4%) |
Mkt cap ! $56.76M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.5¢ | 1.3¢ | $76.04K | 5.442M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 450000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 9713598 | 7 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |